| Oct 3 |
HOPE Therapeutics and NRx Pharmaceuticals acquires a West Coast psychiatric clinic
|
| Oct 3 |
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire a Premier West Coast Interventional Psychiatric Clinic
|
| Sep 30 |
NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announces Completion of Twelve Months of Stability on the First Manufactured Commercial Scale Lot of NRX-100 (Ketamine)
|
| Sep 11 |
NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Featured on Psychiatrist.com
|
| Aug 26 |
HOPE Therapeutics Secures Financing For Ketamine Clinic Expansion
|
| Aug 15 |
NRx Pharmaceuticals, Inc. (NRXP) Q2 2024 Earnings Call Transcript
|
| Aug 14 |
NRx Pharmaceuticals (NASDAQ:NRXP) Reports Second Quarter and Year to Date 2024 Financial Results and Provides Business Update
|
| Aug 13 |
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report Second Quarter and Year to Date 2024 Financial Results on August 14, 2024
|
| Aug 13 |
NRx Pharmaceuticals announces up to $16M senior secured debt financing
|
| Aug 13 |
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Up to $16 Million Senior Secured Debt Financing from Anson Funds
|
